This alteration in the TIME is characterized by a rise in tumor-killing cells including interferon (IFN)γ+ CD8, NK, and NKT-cells, accompanied by a reduction in MDSCs and PD-1hi CD4 T-cells, ultimately reversing the immune-suppressive TME. The gene discussed is CD4; the disease is neoplasm.